MLB: Astros activate RHP Jose Urquidy to start vs. Yankees

Date:

Share post:


The Houston Astros activated right-hander Jose Urquidy from the 60-day injured list to start Sunday’s game against the host New York Yankees.

Urquidy, who had been sidelined due to right shoulder discomfort, last pitched for the Astros on April 30 in a 4-3 win over the Philadelphia Phillies.

The 28-year-old is 2-2 with a 5.20 ERA in six starts this season. He is 26-15 with a 3.85 ERA, 304 strikeouts and 82 walks over 69 career games (66 starts) with Houston.

Urquidy’s only career start against the Yankees was June 26, 2022, when he received a no-decision. He allowed Giancarlo Stanton’s homer for the only hit he gave up in seven innings, and the Yankees won on a game-ending, three-run blast by Aaron Judge in the 10th inning.

Also on Sunday, the Astros optioned left-hander Parker Mushinski to Triple-A Sugar Land and designated right-hander Spenser Watkins for assignment.

Mushinski, 27, has yet to record a decision and has a 2.79 ERA in eight relief appearances this season.

Watkins, 30, owns a 7-13 record with a 5.85 ERA in 39 career games (30 starts) with the Baltimore Orioles.

–Field Level Media

spot_img

Related articles

MLB: Pirates sign LHP Caleb Ferguson to 1-year contract

The Pittsburgh Pirates announced the signing of left-hander Caleb Ferguson to a one-year contract on Friday. The Pirates did...

MLB: Jays, Vladimir Guerrero Jr. avoid arbitration with $28.5M deal

One year after earning a record salary through arbitration, Vladimir Guerrero Jr. and the Toronto Blue Jays avoided...

MLB: Eight Astros avoid arbitration; Framber Valdez lands reported $18M

The Houston Astros came to terms on one-year contracts for all eight of their arbitration-eligible players on Thursday,...

MLB: Cardinals heading to arbitration with Lars Nootbaar, 2 others

The St. Louis Cardinals did not reach deals with three arbitration-eligible players - outfielder Lars Nootbaar, outfielder/second baseman...

FREE

Get the most important breaking news and analyses for Free.

Thank you for subscribing

Something went wrong.